| scholarly article | Q13442814 |
| P50 | author | Martine Aiach | Q75842644 |
| Ivan Bièche | Q37240788 | ||
| David M. Smadja | Q41895761 | ||
| Bernard Le Bonniec | Q57543216 | ||
| Pascale Gaussem | Q57947811 | ||
| P2093 | author name string | Aymeric Amelot | |
| Agnès Basire | |||
| Aurélie Conte | |||
| P2860 | cites work | Activation of endothelial cell protease activated receptor 1 by the protein C pathway | Q24299215 |
| Induction of Apoptosis in Vascular Cells by Plasminogen Activator Inhibitor-1 and High Molecular Weight Kininogen Correlates with Their Anti-Adhesive Properties | Q24300523 | ||
| Design, synthesis, and biological characterization of a peptide-mimetic antagonist for a tethered-ligand receptor | Q28343653 | ||
| Plasminogen-activator inhibitor type 1 and coronary artery disease | Q33942520 | ||
| Characterization of two types of endothelial progenitor cells and their different contributions to neovasculogenesis. | Q34286784 | ||
| Role of the matrix metalloproteinase and plasminogen activator-plasmin systems in angiogenesis. | Q34307809 | ||
| The roles of alpha 2-antiplasmin and plasminogen activator inhibitor 1 (PAI-1) in the inhibition of clot lysis | Q72595310 | ||
| Failure of thrombus to resolve in urokinase-type plasminogen activator gene-knockout mice: rescue by normal bone marrow-derived cells | Q73013976 | ||
| Neovascularization during venous thrombosis organization: a preliminary study | Q73153341 | ||
| Ischemia- and cytokine-induced mobilization of bone marrow-derived endothelial progenitor cells for neovascularization | Q77323614 | ||
| Topology of the stable serpin-protease complexes revealed by an autoantibody that fails to react with the monomeric conformers of antithrombin | Q78168262 | ||
| Vascular endothelial growth factor enhances venous thrombus recanalisation and organisation | Q78830684 | ||
| Endothelial precursor cells as a model of tumor endothelium: characterization and comparison with mature endothelial cells | Q79107461 | ||
| In vitro shear stress modulates antithrombogenic potentials of human endothelial progenitor cells | Q79553999 | ||
| Shear stress contributes to t-PA mRNA expression in human endothelial progenitor cells and nonthrombogenic potential of small diameter artificial vessels | Q82603851 | ||
| Blockade of angiogenesis by small molecule antagonists to protease-activated receptor-1: association with endothelial cell growth suppression and induction of apoptosis | Q83091770 | ||
| High urokinase expression contributes to the angiogenic properties of endothelial cells derived from circulating progenitors | Q83120357 | ||
| Molecular basis for the relationship between thrombosis and cancer | Q34342948 | ||
| Allele-specific increase in basal transcription of the plasminogen-activator inhibitor 1 gene is associated with myocardial infarction | Q34545496 | ||
| Role of fibronectin assembly in platelet thrombus formation | Q34547245 | ||
| TAFIa, PAI-1 and alpha-antiplasmin: complementary roles in regulating lysis of thrombi and plasma clots | Q34612650 | ||
| Extracellular mediators in atherosclerosis and thrombosis: lessons from thrombin receptor knockout mice | Q35099565 | ||
| Increased VEGFR2 expression during human late endothelial progenitor cells expansion enhances in vitro angiogenesis with up-regulation of integrin alpha(6) | Q35459633 | ||
| Role of blood mononuclear cells in recanalization and vascularization of thrombi: past, present, and future. | Q35548776 | ||
| Functional disruption of alpha4 integrin mobilizes bone marrow-derived endothelial progenitors and augments ischemic neovascularization | Q36227849 | ||
| The role of circulating precursors in vascular repair and lesion formation. | Q36275663 | ||
| Progenitor cells in vascular disease. | Q36275672 | ||
| Angiogenic and cell survival functions of vascular endothelial growth factor (VEGF). | Q36346473 | ||
| Role of beta2-integrins for homing and neovascularization capacity of endothelial progenitor cells | Q36402579 | ||
| Clinical and therapeutical implications of EPC biology in atherosclerosis | Q36517055 | ||
| Endothelial progenitor cells: characterization, in vitro expansion, and prospects for autologous cell therapy. | Q36763667 | ||
| A role for proteinase-activated receptor-1 in inflammatory bowel diseases | Q37602792 | ||
| Circulating endothelial progenitor cells, vascular function, and cardiovascular risk | Q39513285 | ||
| Blocking the protease-activated receptor 1-4 heterodimer in platelet-mediated thrombosis | Q40310781 | ||
| Shear stress induces endothelial differentiation from a murine embryonic mesenchymal progenitor cell line | Q40402442 | ||
| Fluid shear stress induces differentiation of Flk-1-positive embryonic stem cells into vascular endothelial cells in vitro | Q40485462 | ||
| PAR1 antagonism protects against experimental liver fibrosis. Role of proteinase receptors in stellate cell activation | Q40591380 | ||
| Intramyocardial transplantation of autologous endothelial progenitor cells for therapeutic neovascularization of myocardial ischemia | Q40608302 | ||
| Real-time reverse transcription-PCR assay for future management of ERBB2-based clinical applications | Q40803186 | ||
| Endothelial protein C receptor (CD201) explicitly identifies hematopoietic stem cells in murine bone marrow | Q42070051 | ||
| Role and localization of urokinase receptor in the formation of new microvascular structures in fibrin matrices | Q42113244 | ||
| Thrombomodulin prolongs thrombin-induced extracellular signal-regulated kinase phosphorylation and nuclear retention in endothelial cells | Q43576482 | ||
| Interleukin-8 administration enhances venous thrombosis resolution in a rat model | Q43649957 | ||
| Pepducin-based intervention of thrombin-receptor signaling and systemic platelet activation | Q44161523 | ||
| Blockade of the thrombin receptor protease-activated receptor-1 with a small-molecule antagonist prevents thrombus formation and vascular occlusion in nonhuman primates. | Q44285592 | ||
| Isolation and characterization of endothelial progenitor cells from mouse embryos. | Q48445583 | ||
| Recruitment of labelled monocytes by experimental venous thrombi. | Q50504779 | ||
| Endothelial progenitor cells are recruited into resolving venous thrombi. | Q50768941 | ||
| The angiopoietin pathway is modulated by PAR-1 activation on human endothelial progenitor cells. | Q50933010 | ||
| The 4G/5G PAI-1 polymorphism influences the endothelial response to IL-1 and the modulatory effect of pravastatin. | Q54589738 | ||
| PAR-1 activation on human late endothelial progenitor cells enhances angiogenesis in vitro with upregulation of the SDF-1/CXCR4 system. | Q54645645 | ||
| Gene-environment interaction in the determination of levels of haemostatic variables involved in thrombosis and fibrinolysis | Q57243120 | ||
| Fibrin and Activated Platelets Cooperatively Guide Stem Cells to a Vascular Injury and Promote Differentiation Towards an Endothelial Cell Phenotype | Q57790274 | ||
| P433 | issue | 3 | |
| P921 | main subject | endothelium | Q111140 |
| P304 | page(s) | 975-986 | |
| P577 | publication date | 2008-06-01 | |
| P1433 | published in | Journal of Cellular and Molecular Medicine | Q1524063 |
| P1476 | title | Thrombin bound to a fibrin clot confers angiogenic and haemostatic properties on endothelial progenitor cells | |
| P478 | volume | 12 |
| Q47378554 | CD34+ cells augment endothelial cell differentiation of CD14+ endothelial progenitor cells in vitro |
| Q37661456 | Clinical implication of endothelial progenitor cells |
| Q27021049 | Coagulation and the vessel wall in pulmonary embolism |
| Q47694726 | Egfl7 Represses the Vasculogenic Potential of Human Endothelial Progenitor Cells |
| Q59584855 | Fibrin acts as biomimetic niche inducing both differentiation and stem cell marker expression of early human endothelial progenitor cells |
| Q35889139 | High-density lipoprotein exerts vasculoprotection via endothelial progenitor cells |
| Q28743314 | Improved survival, vascular differentiation and wound healing potential of stem cells co-cultured with endothelial cells |
| Q42439415 | Interleukin 8 is differently expressed and modulated by PAR-1 activation in early and late endothelial progenitor cells. |
| Q57767239 | Neutrophils as new conductors of vascular homeostasis |
| Q57767168 | Stem-Cell-Based Therapies for Vascular Regeneration in Peripheral Artery Diseases |
| Q98465009 | The Relationship Between Nailfold Microcirculation and Retinal Microcirculation in Healthy Subjects |
| Q33917367 | Thrombin and exercise similarly influence expression of cell cycle genes in cultured putative endothelial progenitor cells |
| Q45130928 | Thrombin as important factor for cutaneous wound healing: comparison of fibrin biomatrices in vitro and in a rat excisional wound healing model. |
| Q53221287 | Thrombin receptor PAR-1 activation on endothelial progenitor cells enhances chemotaxis-associated genes expression and leukocyte recruitment by a COX-2-dependent mechanism. |
| Q38836736 | Thrombin-unique coagulation system protein with multifaceted impacts on cancer and metastasis. |
| Q57767280 | Thérapie génique et cellulaire dans le traitement des pathologies ischémiques des membres inférieurs |
| Q51059554 | Upregulation of MicroRNA-126 Contributes to Endothelial Progenitor Cell Function in Deep Vein Thrombosis via Its Target PIK3R2 |
| Q92394708 | Vasculogenic Stem and Progenitor Cells in Human: Future Cell Therapy Product or Liquid Biopsy for Vascular Disease |
Search more.